Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Effects of gender and menopausal status-24-month results

被引：0
|
作者：
Dobnig, H. [1 ]
Warner, M. R. [2 ]
Langdahl, B. L. [3 ]
Moericke, R. [4 ]
See, K. [2 ]
Marin, F. [5 ]
机构：
[1] Med Univ Graz, Graz, Austria
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[4] Clin Res Lab, Magdeburg, Germany
[5] Eli Lilly & Co, Lilly Res Labs, Madrid, Spain
来源：
BONE | 2009年 / 44卷 / 02期
关键词：
D O I：
10.1016/j.bone.2009.03.089
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 42 条
  • [1] Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
    Langdahl, B. L.
    Marin, F.
    Shane, E.
    Dobnig, H.
    Zanchetta, J. R.
    Maricic, M.
    Krohn, K.
    See, K.
    Warner, M. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (12) : 2095 - 2104
  • [2] Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
    B. L. Langdahl
    F. Marin
    E. Shane
    H. Dobnig
    J. R. Zanchetta
    M. Maricic
    K. Krohn
    K. See
    M. R. Warner
    [J]. Osteoporosis International, 2009, 20 : 2095 - 2104
  • [3] TERIPARATIDE VERSUS ALENDRONATE FOR TREATING GLUCOCORTICOID-INDUCED OSTEOPOROSIS: 36-MONTH RESULTS
    Devogelaer, J. -P.
    Warner, M.
    Saag, K.
    Zanchetta, J.
    Adler, R.
    Eastell, R.
    See, K.
    Dalsky, G.
    Krohn, K.
    Krege, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 7 - 7
  • [4] Teriparatide versus Alendronate for Treatment of Glucocorticoid-Induced Osteoporosis: 36-month Results
    Saag, K. G.
    Zanchetta, J. R.
    Devogelaer, J. P.
    Adler, R. A.
    See, K.
    Dalsky, G. P.
    Krohn, K.
    Krege, J. H.
    Warner, M. R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S49 - S49
  • [5] Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results
    Saag, Kenneth G.
    Zanchetta, Jose R.
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Eastell, Richard
    See, Kyoungah
    Dalsky, Gail P.
    Krohn, Kelly
    Krege, John H.
    Warner, Margaret R.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S939 - S939
  • [6] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Babb, Richard R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12): : 1302 - 1303
  • [7] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Saag, Kenneth G.
    Shane, Elizabeth
    Boonen, Steven
    Marin, Fernando
    Donley, David W.
    Taylor, Kathleen A.
    Dalsky, Gail P.
    Marcus, Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2028 - 2039
  • [8] Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
    Saag, Kenneth G.
    Zanchetta, Jose R.
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Eastell, Richard
    See, Kyoungah
    Krege, John H.
    Krohn, Kelly
    Warner, Margaret R.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3346 - 3355
  • [9] Is teriparatide or alendronate the best treatment for glucocorticoid-induced osteoporosis?
    Woolf, Anthony D.
    Akesson, Kristina
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (05): : 236 - 237
  • [10] Is teriparatide or alendronate the best treatment for glucocorticoid-induced osteoporosis?
    Anthony D Woolf
    Kristina Åkesson
    [J]. Nature Clinical Practice Rheumatology, 2008, 4 : 236 - 237
12345